586 related articles for article (PubMed ID: 30975595)
1. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
Strike C; Watson TM
Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
[TBL] [Abstract][Full Text] [Related]
2. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.
Irvine MA; Kuo M; Buxton JA; Balshaw R; Otterstatter M; Macdougall L; Milloy MJ; Bharmal A; Henry B; Tyndall M; Coombs D; Gilbert M
Addiction; 2019 Sep; 114(9):1602-1613. PubMed ID: 31166621
[TBL] [Abstract][Full Text] [Related]
3. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
Kolla G; Strike C
Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
[TBL] [Abstract][Full Text] [Related]
4. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
Yeo Y; Johnson R; Heng C
Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
[TBL] [Abstract][Full Text] [Related]
5. Harm reduction and the opioid crisis: Emerging policy challenges.
Greer A; Ritter A
Int J Drug Policy; 2019 Sep; 71():139-141. PubMed ID: 31160155
[No Abstract] [Full Text] [Related]
6. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions?
Bardwell G; Collins AB; McNeil R; Boyd J
Harm Reduct J; 2017 Dec; 14(1):77. PubMed ID: 29212507
[TBL] [Abstract][Full Text] [Related]
7. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
8. The role of take-home naloxone in the epidemic of opioid overdose involving illicitly manufactured fentanyl and its analogs.
Kim HK; Connors NJ; Mazer-Amirshahi ME
Expert Opin Drug Saf; 2019 Jun; 18(6):465-475. PubMed ID: 31033357
[TBL] [Abstract][Full Text] [Related]
9. Opioid overdose prevention and naloxone rescue kits: what we know and what we don't know.
Kerensky T; Walley AY
Addict Sci Clin Pract; 2017 Jan; 12(1):4. PubMed ID: 28061909
[TBL] [Abstract][Full Text] [Related]
10. The opioid crisis in Canada: a national perspective.
Belzak L; Halverson J
Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):224-233. PubMed ID: 29911818
[TBL] [Abstract][Full Text] [Related]
11. An emergency response to the opioid overdose crisis in Canada: a regulated opioid distribution program.
Tyndall M
CMAJ; 2018 Jan; 190(2):E35-E36. PubMed ID: 29335260
[No Abstract] [Full Text] [Related]
12. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
Fairbairn N; Coffin PO; Walley AY
Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
[TBL] [Abstract][Full Text] [Related]
13. Barriers to naloxone use and acceptance among opioid users, first responders, and emergency department providers in New Hampshire, USA.
Bessen S; Metcalf SA; Saunders EC; Moore SK; Meier A; McLeman B; Walsh O; Marsch LA
Int J Drug Policy; 2019 Dec; 74():144-151. PubMed ID: 31590090
[TBL] [Abstract][Full Text] [Related]
14. A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic.
Zahan R; Osgood ND; Plouffe R; Orpana H
Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673354
[TBL] [Abstract][Full Text] [Related]
15. Drug checking as a potential strategic overdose response in the fentanyl era.
Laing MK; Tupper KW; Fairbairn N
Int J Drug Policy; 2018 Dec; 62():59-66. PubMed ID: 30359874
[TBL] [Abstract][Full Text] [Related]
16. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA
Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839
[TBL] [Abstract][Full Text] [Related]
17. CAEP Position Statement: Emergency department management of people with opioid use disorder.
Koh JJ; Klaiman M; Miles I; Cook J; Kumar T; Sheikh H; Dong K; Orkin AM; Ali S; Shouldice E
CJEM; 2020 Nov; 22(6):768-771. PubMed ID: 33028446
[TBL] [Abstract][Full Text] [Related]
18. Fentanyl misuse.
Ruzycki S; Yarema M
CMAJ; 2016 Jun; 188(9):673. PubMed ID: 27091798
[No Abstract] [Full Text] [Related]
19. A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018.
Ansari B; Tote KM; Rosenberg ES; Martin EG
Public Health Rep; 2020; 135(1_suppl):100S-127S. PubMed ID: 32735190
[TBL] [Abstract][Full Text] [Related]
20. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program.
Karamouzian M; Kuo M; Crabtree A; Buxton JA
Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
